Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets
Seminars in Liver Disease · 01.08.2024 · 44 (03) · 319-332
DOI: 10.1055/a-2338-9261 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.08.2024. Verfasst von Shengying Qian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, China. Hauptthemen laut MEDLINE: Fatty Liver. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 117 Literaturangaben. Gefördert von: the Natural Science Foundation of Shanghai, the Natural Science Foundation of China, the National Key Research and Development Program of China.
Abstract (Originalsprache)
Alcohol-related liver disease (ALD) and metabolic dysfunction-associated steatotic liver disease (MASLD), two main types of steatotic liver disease (SLDs), are characterized by a wide spectrum of several different liver disorders, including simple steatosis, steatohepatitis, cirrhosis, and hepatocellular carcinoma. Multiple immune cell-mediated inflammatory responses not only orchestrate the killing and removal of infected/damaged cells but also exacerbate the development of SLDs when excessive or persistent inflammation occurs. In recent years, single-cell and spatial transcriptome analyses have revealed the heterogeneity of liver-infiltrated immune cells in ALD and MASLD, revealing a new immunopathological picture of SLDs. In this review, we will emphasize the roles of several key immune cells in the pathogenesis of ALD and MASLD and discuss inflammation-based approaches for effective SLD intervention. In conclusion, the study of immunological mechanisms, especially highly specific immune cell population functions, may provide novel therapeutic opportunities for this life-threatening disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Department of Infectious Diseases, Shanghai Jiao Tong University School of Medicine, Ruijin Hospital, Shanghai, China.
Förderung
- the Natural Science Foundation of Shanghai
- the Natural Science Foundation of China
- the National Key Research and Development Program of China
Zitieren
APA
Qian, S., Wang, X., Chen, Y., Zai, Q., & He, Y. (2024). Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets. Seminars in Liver Disease, 44(03), 319-332. https://doi.org/10.1055/a-2338-9261
Vancouver
Qian S, Wang X, Chen Y, Zai Q, He Y. Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets. Seminars in Liver Disease. 2024;44(03):319-332. doi:10.1055/a-2338-9261
BibTeX
@article{Qian2024,
author = {Qian, Shengying and Wang, Xiaolin and Chen, Yingfen and Zai, Qiuhong and He, Yong},
title = {Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets},
journal = {Seminars in Liver Disease},
year = {2024},
volume = {44},
number = {03},
pages = {319--332},
doi = {10.1055/a-2338-9261}
}
EUVIMED